Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine and Clonazepam for Panic Disorder with Depression
NCT00031317Phase 4Completed
- Sponsor
- National Institute of Mental Health
- Start
- Feb 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in panic disorder and major depressive disorder (MDD) comparing Paroxetine + Clonazepam with Paroxetine + Placebo (2 arms). Primary endpoint: Onset of clinical response. Started Feb 2002; status: completed.
02
Drugs
clonazepam
03
Conditions
panic disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00031317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031317.